PPA
KITE

Parametric Portfolio Associates’s Kite Pharma, Inc. KITE Stock Holding History

Parametric Portfolio Associates’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-24,567
Closed -$4.42M – 4009
2017
Q3 		$4.42M Sell
24,567
-10,266
-29% -$1.43M ﹤0.01% 1954
2017
Q2 		$3.61M Sell
34,833
-1,132
-3% -$92.4K ﹤0.01% 2068
2017
Q1 		$2.82M Buy
35,965
+17,588
+96% +$1.09M ﹤0.01% 2221
2016
Q4 		$824K Sell
18,377
-6,952
-27% -$341K ﹤0.01% 2945
2016
Q3 		$1.42M Buy
25,329
+6,274
+33% +$350K ﹤0.01% 2591
2016
Q2 		$953K Buy
19,055
+2,581
+16% +$127K ﹤0.01% 2864
2016
Q1 		$756K Buy
16,474
+12,949
+367% +$627K ﹤0.01% 3101
2015
Q4 		$217K Buy
+3,525
New +$248K ﹤0.01% 3701

Parametric Portfolio Associates's KITE Position: Q4 2017 in Review

Parametric Portfolio Associates sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 24,567 shares — an estimated $4.42M sold.

Parametric Portfolio Associates first reported a position in KITE in Q4 2015 and held it in 8 quarters. The position peaked at $4.42M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Parametric Portfolio Associates reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Parametric Portfolio Associates sold 24,567 Kite Pharma, Inc. shares in Q4 2017, an estimated $4.42M.
  • Parametric Portfolio Associates first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 8 quarters.
  • Parametric Portfolio Associates's Kite Pharma, Inc. position peaked at $4.42M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Parametric Portfolio Associates's 13F filing for Q4 2017, filed 14 Feb 2018.